EditorialEditorial
Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer
Lei-Jie Dai, Yu-Wei Li, Ding Ma, Zhi-Ming Shao and Yi-Zhou Jiang
Cancer Biology & Medicine October 2023, 20 (10) 689-694; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0286
Lei-Jie Dai
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Yu-Wei Li
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Ding Ma
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Zhi-Ming Shao
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Yi-Zhou Jiang
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
Article Figures & Data
Figures
In this issue
Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer
Lei-Jie Dai, Yu-Wei Li, Ding Ma, Zhi-Ming Shao, Yi-Zhou Jiang
Cancer Biology & Medicine Oct 2023, 20 (10) 689-694; DOI: 10.20892/j.issn.2095-3941.2023.0286
Jump to section
- Article
- Unique mechanism of next-generation ADCs
- Next-generation ADC reshapes the treatment landscape for advanced HER2-positive breast cancer
- Value of next-generation ADCs in the treatment of HER2-low breast cancer
- Perspectives on the precision management of HER2-expressing breast cancer in the era of next-generation ADCs
- Next-generation ADCs redefine treatment strategies and research approaches for breast cancer
- Conflict of interest statement
- Author contributions
- Footnotes
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.